Lineage Cell Therapeutics (LCTX) Cost of Revenue (2011 - 2025)
Lineage Cell Therapeutics (LCTX) posted Cost of Revenue of $36,000 for Q1 2025, down 63.3% from $98,000 a year earlier and down 76.6% from the prior quarter.
Powered by 
Analysis
Lineage Cell Therapeutics (LCTX) Cost of Revenue (2011 - 2025) Analysis & Trends
For the trailing twelve months through Mar 31, 2025, Cost of Revenue at Lineage Cell Therapeutics was $272,000, down 58.2% year-over-year; for FY2024, it came in at $334,000, down 50.2% from FY2023.
- Annual Cost of Revenue has declined for three consecutive years, with a five-year compound annual growth rate of -4.1% (FY2019 to FY2024).
- In prior years, Lineage Cell Therapeutics' Cost of Revenue was $671,000 in FY2023 (-7.8%), $728,000 in FY2022 (-48.9%), $1.43 million in FY2021 (+270.4%) and $385,000 in FY2020 (-6.6%).
- The Q1 2025 figure stands as the lowest quarterly Cost of Revenue since Q3 2018.
- On a year-over-year basis, Cost of Revenue has declined in each of the last five quarters, with an average decline of 22.7% over the last eight quarters.
- The strongest year-over-year quarter for Cost of Revenue in the past five years was Q3 2021, with growth of 865.7%; the weakest was Q3 2024, with a decline of 77.5%.
- According to Business Quant data, Cost of Revenue for the three prior quarters was $154,000 (Q4 2024), $38,000 (Q3 2024) and $44,000 (Q2 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.27 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 8.05 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.29 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 4.40 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.71 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.52 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.81 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.58 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.09 Bn |
| 10 | Lineage Cell Therapeutics | 235.20 Mn | 33.61 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 36,000.00 |
| Dec 31, 2024 | 154,000.00 |
| Sep 30, 2024 | 38,000.00 |
| Jun 30, 2024 | 44,000.00 |
| Mar 31, 2024 | 98,000.00 |
| Dec 31, 2023 | 256,000.00 |
| Sep 30, 2023 | 169,000.00 |
| Jun 30, 2023 | 127,000.00 |
| Mar 31, 2023 | 119,000.00 |
| Dec 31, 2022 | 102,000.00 |
| Sep 30, 2022 | 235,000.00 |
| Jun 30, 2022 | 215,000.00 |
| Mar 31, 2022 | 176,000.00 |
| Dec 31, 2021 | 204,000.00 |
| Sep 30, 2021 | 985,000.00 |
| Jun 30, 2021 | 125,000.00 |
| Mar 31, 2021 | 112,000.00 |
| Dec 31, 2020 | 114,000.00 |
| Sep 30, 2020 | 102,000.00 |
| Jun 30, 2020 | 75,000.00 |
API Access
Lineage Cell Therapeutics Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=LCTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "LCTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=LCTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();